KALA BIO (KALA) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
KALA BIO insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $249K of KALA stock on the open market.
Get emailed when insiders cluster-buy stocks like KALA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
KALA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $958K | 8 |
| Q3 2025 | — | 0 | $347K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 KALA BIO, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $249K. 0 of 10 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 24SEC | Mark T IwickiDirector | Sell | 154,894103,540 held (−60%) | $0.81 | $125K | -63.7% | — |
| Oct 24SEC | Todd BazemoreDirector | Sell | 47,76835,932 held (−57%) | $0.83 | $40K | -64.6% | — |
| Oct 24SEC | Romulus K BrazzellSee Remarks | Sell | 46,74835,952 held (−57%) | $0.83 | $39K | -64.6% | — |
| Oct 24SEC | Mary ReumuthCFO | Sell | 32,23029,873 held (−52%) | $0.83 | $27K | -64.6% | — |
| Oct 24SEC | Darius KharabiChief Business Officer | Sell | 20,80641,760 held (−33%) | $0.83 | $17K | -64.6% | — |
| Oct 24SEC | Mary ReumuthCFO | Sell | 96728,906 held (−3%) | $0.82 | $793 | -64.1% | — |
| Oct 2SEC | Julian BakerFormer 10% Owner | Sell | 462,967425,006 held (−52%) | $1.38 | $639K | -78.7% | — |
| Oct 2SEC | Julian BakerFormer 10% Owner | Sell | 195,425887,973 held (−18%) | $1.60 | $313K | -81.6% | — |
| Oct 2SEC | Julian BakerFormer 10% Owner | Sell | 50,64046,480 held (−52%) | $1.38 | $70K | -78.7% | — |
| Oct 2SEC | Julian BakerFormer 10% Owner | Sell | 21,37697,120 held (−18%) | $1.60 | $34K | -81.6% | — |
Insiders at KALA BIO, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Julian BakerFormer 10% Owner | — | $1.1M | Oct 2, 2025 | — |
| Mark T IwickiDirector | — | $125K | Oct 24, 2025 | — |
| Todd BazemoreDirector | — | $40K | Oct 24, 2025 | — |
| Romulus K BrazzellSee Remarks | — | $39K | Oct 24, 2025 | — |
| Mary ReumuthCFO | — | $28K | Oct 24, 2025 | — |
| Darius KharabiChief Business Officer | — | $17K | Oct 24, 2025 | — |
KALA stock: common questions
Are KALA BIO, Inc. insiders buying KALA stock?
In the past 12 months, 0 insiders reported open-market purchases of KALA worth $0.
Are KALA BIO, Inc. insiders selling KALA stock?
5 insiders reported sales worth $249K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is KALA's 52-week range?
Over the past year KALA has traded between $0.29 and $77.50. It last closed at $0.29 on Oct 9, 2026.